chlordiazepoxide has been researched along with ondansetron in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Emmett-Oglesby, MW; Lal, H; Prather, PL; Rezazadeh, SM | 1 |
| Barnes, NM; Cheng, CH; Costall, B; Ge, J; Kelly, ME; Naylor, RJ | 1 |
| Goudie, AJ; Leathley, MJ | 2 |
| Higgins, GA; Joharchi, N; Nguyen, P; Sellers, EM | 1 |
| File, SE; Johnston, AL | 1 |
| Bill, DJ; Dourish, CT; Fletcher, A; Grewal, SS; Shepherd, JK | 1 |
| Bixler, MA; Mele, PC; O'Halloran, KP; Verrees, JF; Winsauer, PJ | 1 |
| Emmett-Oglesby, MW; Hooper, ML; Lal, H; Lane, JD; Lytle, DA; Prather, PL; Rezazadeh, SM; Rowan, GA | 1 |
| Meert, TF | 1 |
| Bonner, N; Downey, R; Engeland, K; Jackson, M; Limebeer, CL; Morris, H; Navaratnam, R; Parker, LA; Rock, EM; Sticht, MA | 1 |
1 review(s) available for chlordiazepoxide and ondansetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for chlordiazepoxide and ondansetron
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
Topics: Animals; Anti-Anxiety Agents; Chlordiazepoxide; Flumazenil; Imidazoles; Learning; Male; Ondansetron; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1992 |
Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Topics: Animals; Anti-Anxiety Agents; Antiemetics; Behavior, Animal; Benzamides; Brain Chemistry; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlordiazepoxide; Fenclonine; Granisetron; Indazoles; Male; Mice; Neurotransmitter Agents; Ondansetron; Receptors, Cholecystokinin; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Stereoisomerism | 1992 |
Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.
Topics: Animals; Chlordiazepoxide; Conditioning, Operant; Female; Ondansetron; Rats; Rats, Wistar; Reinforcement Schedule; Serotonin Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
Topics: Animals; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Drug Implants; Imidazoles; Male; Morphine Dependence; Naloxone; Ondansetron; Pyrimidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Substance Withdrawal Syndrome; Tropanes | 1991 |
Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
Topics: Animals; Anti-Anxiety Agents; Body Weight; Chlordiazepoxide; Dose-Response Relationship, Drug; Eating; Female; Imidazoles; Ondansetron; Rats; Rats, Inbred Strains; Serotonin Antagonists; Substance Withdrawal Syndrome | 1990 |
Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
Topics: Animals; Anxiety; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlordiazepoxide; Granisetron; Imidazoles; Indazoles; Male; Motor Activity; Ondansetron; Rats; Serotonin Antagonists; Social Behavior | 1989 |
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Ondansetron; Piperazines; Posture; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1994 |
Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Chlordiazepoxide; Dose-Response Relationship, Drug; Eating; Male; Ondansetron; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
Topics: Animals; Anti-Anxiety Agents; Chlordiazepoxide; Conditioning, Psychological; Discrimination Learning; Flumazenil; Male; Ondansetron; Pentylenetetrazole; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1993 |
Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Chlordiazepoxide; Citalopram; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Male; Ondansetron; Rats; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping.
Topics: Animals; Anticipation, Psychological; Antiemetics; Cannabinoids; Chlordiazepoxide; Conditioning, Psychological; Dronabinol; Electroshock; Fear; Hypnotics and Sedatives; Lithium Chloride; Male; Motor Activity; Nausea; Ondansetron; Rats; Rats, Sprague-Dawley | 2014 |